Skip to main content
. 2015 Nov 6;71(2):272–274. doi: 10.1111/all.12781

Figure 1.

Figure 1

Sublingual challenge tests with increasing doses of rMal d 1. The percentage of 72 birch pollen‐allergic patients developing oral allergy syndromes (OAS) upon sublingual challenge with indicated doses of rMal d 1 is shown; challenges were stopped when OAS occurred.